NephroScan FDA Approval History
FDA Approved: Yes (First approved February 22, 2022)
Brand name: NephroScan
Generic name: technetium Tc 99m succimer
Dosage form: Injection Kit
Treatment for: Diagnosis and Investigation
NephroScan (kit for the preparation of technetium Tc 99m succimer injection) is a radioactive diagnostic agent indicated for use as an aid in the scintigraphic evaluation of renal parenchymal disorders.
Development timeline for NephroScan
|Feb 21, 2022||Approval FDA Approves NephroScan (Kit for the Preparation of Technetium Tc 99m Succimer Injection) for Radiodiagnostic Imaging|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.